Sisram Medical Ltd SRAMF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- $3.60–3.60
- Bid/Ask
- $0.00 / $0.57
- Market Cap
- —
- Volume/Avg
- 20,000 / 20,000
Key Statistics
- Price/Earnings (Normalized)
- 54.92
- Price/Sales
- 7.38
- Dividend Yield (Trailing)
- 0.25%
- Dividend Yield (Forward)
- 0.07%
- Total Yield
- 0.25%
Company Profile
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,080
- Website
- https://www.sisram-medical.com
Comparables
Valuation
|
Metric
|
SRAMF
|
06929
|
SYAB
|
|---|---|---|---|
Price/Earnings (Normalized) | 54.92 | 8.71 | 80.42 |
Price/Book Value | 4.88 | 1.11 | 0.98 |
Price/Sales | 7.38 | 2.67 | 0.88 |
Price/Cash Flow | 34.45 | 10.06 | 8.20 |
Price/Earnings
SRAMF
06929
SYAB
Financial Strength
|
Metric
|
SRAMF
|
06929
|
SYAB
|
|---|---|---|---|
Quick Ratio | 1.88 | 8.48 | 1.03 |
Current Ratio | 2.92 | 9.77 | 1.16 |
Interest Coverage | 18.70 | 291.76 | 2.17 |
Quick Ratio
SRAMF
06929
SYAB
Profitability
|
Metric
|
SRAMF
|
06929
|
SYAB
|
|---|---|---|---|
Return on Assets (Normalized) | 6.24% | 12.21% | 0.86% |
Return on Equity (Normalized) | 8.36% | 13.34% | 1.87% |
Return on Invested Capital (Normalized) | 7.71% | 10.42% | 2.44% |
Return on Assets
SRAMF
06929
SYAB
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Htvjcyh | Rlnbwpg | $184.2 Bil | |
SYK
| Stryker Corp | Tfjyzlkld | Hqq | $125.1 Bil | |
MDT
| Medtronic PLC | Bmbnqkbvr | Mspwst | $108.5 Bil | |
BSX
| Boston Scientific Corp | Djlznfcb | Zgvjnqs | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Lmvqqdprk | Nqdrc | $51.4 Bil | |
DXCM
| DexCom Inc | Wmxrmqtmyr | Yvsw | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Whrfdvwzm | Qtl | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Frqnyrwd | Zjghxd | $24.4 Bil | |
ALGN
| Align Technology Inc | Nfydzlk | Lzjqxl | $21.7 Bil | |
PODD
| Insulet Corp | Bbvkpyzrh | Clzjkr | $12.2 Bil |